Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease
Toshiya Machida; Taku Obara; Makoto Miyazaki; Jun Inoue; Nariyasu Mano;
10.1016/j.aohep.2022.100699
NAFLD: Challenges and opportunities to address the public health challenge in Latin America
Juan Pablo Arab; Luis Antonio Díaz; Melisa Dirchwolf; Henry Mark; Jeffrey V. Lazarus; Elly Vaughan; Nahum Méndez-Sánchez; Claudia P. de Oliveira; Adrián Gadano; Marco Arrese;
10.1016/j.aohep.2021.100359
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589